期刊文献+
共找到509篇文章
< 1 2 26 >
每页显示 20 50 100
Histological Assessment of Bone Regeneration in the Maxilla with Homologous Bone Graft:A Feasible Option for Maxillary Bone Reconstruction
1
作者 Sergio Henrique Gonçalves Motta Ana Paula Ramos Soares +1 位作者 Juliana Campos Hasse Fernandes Gustavo Vicentis Oliveira Fernandes 《Journal of Renewable Materials》 EI CAS 2024年第1期131-148,共18页
Bone biomaterials have been increasingly used to reconstruct maxillary atrophic ridges.Thus,the aim of this study was to evaluate bone reconstruction in the maxilla using a homologous cortico-cancellous FFB(lyophilize... Bone biomaterials have been increasingly used to reconstruct maxillary atrophic ridges.Thus,the aim of this study was to evaluate bone reconstruction in the maxilla using a homologous cortico-cancellous FFB(lyophilized)graft and verify its reliability.Eight individuals were included from 2014 to 2018.The first surgery was performed to install homologous bone blocks in the maxilla.The period of the second intervention varied between 5 months and 15 days to 11 months(≈7.93 months).The biopsies were taken from the central region of the matured graft during the surgery for implant placement.All patients presented clinical and radiographic conditions for the installation of dental implants.There was a 100%of survival rate.The histological assessment showed that the homologous block bone graft was an osteoconductive biomaterial,with connective tissue present,and newly formed bone juxtaposed on its surface.There were bone trabeculae with osteocytes and active osteoblasts with connective tissue in the mineralization process;the remodeling process can be found through the reverse lines.A limited focus of necrosis with fibrosis was detected,with small resorption and areas of inflammatory infiltrate,but without clinical significance.The homologous block bone graft can be considered a feasible option to substitute the autogenous bone graft(gold standard),with predictable clinical and favorable histological results.The patients had a shorter surgical period,low morbidity,and an unlimited amount of biomaterial available at an accessible cost. 展开更多
关键词 Regeneration bone graft HISTOLOGY HOMOLOGOUS allogenous AUTOGENOUS
下载PDF
After allogenic bone marrow transplantation agent of hemorrhagic cystitis: BK virus
2
作者 Berber Ilhami Koroglu Mustafa +5 位作者 Erkurt Mehmet Ali Oguz Fatih Altintas Ramazan Kaya Emin Kuku Irfan Ulutas Ozkan 《Case Reports in Clinical Medicine》 2013年第5期298-301,共4页
Hemorrhagic cystitis is a common and in its severe form potentially life threatening complication of hematopoietic stem cell transplantation. Hemorrhagic cystitis is defined as a diffuse inflammatory condition of the ... Hemorrhagic cystitis is a common and in its severe form potentially life threatening complication of hematopoietic stem cell transplantation. Hemorrhagic cystitis is defined as a diffuse inflammatory condition of the urinary bladder due to an infectious or noninfectious etiology resulting in bleeding from the bladder mucosa. Hemorrhagic cystitis is characterized by lower urinary tract symptoms including dysuria, hematuria and hemorrhage. The most common cause is a bacterial infection that usually responds promptly to treatment. But chronic and recurrent hemorrhagic cystitis often arises from anticancer chemotherapy or radiotherapy for the treatment of pelvic malignancies. Infectious etiologies are less common causes of chronic hemorrhagic cystitis except in immunocompromised hosts like bone marrow transplant recipients. Hemorrhagic cystitis is a significant complication of bone marrow transplantation which influences economic and survival outcome. Hemorrhagic cystitis can be divided into two classes according to onset time;early and late onset time. Earlyonset hemorrhagic cystitis is commonly associated used with chemo-radiotherapy protocols in some of the preparatory regimens. More than one factor is accused in the etiology of late onset hemorrhagic cystitis. Here, we present a patient whose hematuria started after 54 days from allogeneic stem cell transplantation. 展开更多
关键词 allogenic bone MARROW TRANSPLANTATION
下载PDF
Surface demineralized freeze-dried bone allograft followed by reimplantation in a failed mandibular dental implant
3
作者 Jing Zhang Jie Wang +5 位作者 Jiayi You Xuan Qin Huimin Chen Xiantong Hu Yantao Zhao Yang Xia 《Regenerative Biomaterials》 SCIE EI CSCD 2024年第1期82-93,共12页
The removal of a failed implant with high torque causes significant damage to the surrounding tissue,compromising bone regeneration and subsequent osseointegration in the defect area.Here,we report a case of carrier s... The removal of a failed implant with high torque causes significant damage to the surrounding tissue,compromising bone regeneration and subsequent osseointegration in the defect area.Here,we report a case of carrier screw fracture followed by immediate implant removal,bone grafting and delayed reimplantation.A dental implant with a fractured central carrier screw was removed using the bur-forceps technique.The resulting three-wall bone defect was filled with granular surface demineralized freeze-dried bone allograft(SD-FDBA).Cone-beam computerized tomography was performed at 1week,6months and 15months postoperatively and standardized for quantitative evaluation.The alveolar bone width and height at 15months post-surgery were about 91%of the original values,with a slightly lower bone density,calculated using the gray value ratio.The graft site was reopened and was found to be completely healed with dense and vascularized bone along with some residual bone graft.Reimplantation followed by restoration was performed 8months later.The quality of regenerated bone following SD-FDBA grafting was adequate for osseointegration and longterm implant success.The excellent osteogenic properties of SD-FDBA are attributed to its human origin,cortical bone-like structure,partly demineralized surfaces and bone morphogenetic protein-2-containing nature.Further investigation with more cases and longer follow-up was required to confirm the final clinical effect. 展开更多
关键词 dental implant implant failure allogeneic bone bone regeneration REIMPLANTATION
原文传递
Acellular allogeneic nerve grafting combined with bone marrow mesenchymal stem cell transplantation for the repair of long-segment sciatic nerve defects:biomechanics and validation of mathematical models 被引量:8
4
作者 Ya-jun Li Bao-lin Zhao +2 位作者 Hao-ze Lv Zhi-gang Qin Min Luo 《Neural Regeneration Research》 SCIE CAS CSCD 2016年第8期1322-1326,共5页
We hypothesized that a chemically extracted acellular allogeneic nerve graft used in combination with bone marrow mesenchymal stem cell transplantation would be an effective treatment for long-segment sciatic nerve de... We hypothesized that a chemically extracted acellular allogeneic nerve graft used in combination with bone marrow mesenchymal stem cell transplantation would be an effective treatment for long-segment sciatic nerve defects.To test this,we established rabbit models of 30 mm sciatic nerve defects,and treated them using either an autograft or a chemically decellularized allogeneic nerve graft with or without simultaneous transplantation of bone marrow mesenchymal stem cells.We compared the tensile properties,electrophysiological function and morphology of the damaged nerve in each group.Sciatic nerves repaired by the allogeneic nerve graft combined with stem cell transplantation showed better recovery than those repaired by the acellular allogeneic nerve graft alone,and produced similar results to those observed with the autograft.These findings confirm that a chemically extracted acellular allogeneic nerve graft combined with transplantation of bone marrow mesenchymal stem cells is an effective method of repairing long-segment sciatic nerve defects. 展开更多
关键词 nerve regeneration chemically extracted acellular allogeneic nerve graft AUTOGRAFT bone marrow mesenchymal stem cells sciatic nerve defects BIOMECHANICS ELECTROPHYSIOLOGY morphology neural regeneration
下载PDF
The use of allogeneic cancellous bone graft in bone cavity of jaw cyst
5
作者 朱明仁 李锐球 +3 位作者 吴乃强 李少萍 张雨梅 李伟忠 《Journal of Medical Colleges of PLA(China)》 CAS 1991年第4期379-382,387,共5页
A new method for filling bone cavity with a graft of frozen-decalcified-defatted-driedallogeneic (FDDDA) cancellous bone was described.This method was used for the treatment of cavi-ties after the enucleation of jaw c... A new method for filling bone cavity with a graft of frozen-decalcified-defatted-driedallogeneic (FDDDA) cancellous bone was described.This method was used for the treatment of cavi-ties after the enucleation of jaw cysts in 10 patients from December 1985 to February 1990.Thewounds of 9 patients healed by first intension,but wound infection occurred in one case postopera-tively.The 9 patients,besides the patient who suffered from wound infection,were followed up for5 to 56 months,with an average of 41.1 months.Evidence of recurrence with jaw cyst.was not ob-served. 展开更多
关键词 JAW CYST FILLING bone cavity allogenEIC canellous bone
下载PDF
The study of engraft evidence in allogeneic bone marrow transplantation by 9 short tandem repeats loci
6
《中国输血杂志》 CAS CSCD 2001年第S1期376-,共1页
关键词 bone The study of engraft evidence in allogeneic bone marrow transplantation by 9 short tandem repeats loci
下载PDF
同种异体骨与异种骨对牙周骨下袋缺损再生治疗的疗效对比 被引量:1
7
作者 王金孟 杨智宇 +1 位作者 雷浪 李厚轩 《遵义医科大学学报》 2024年第2期152-158,共7页
目的对比同种异体的Bio-Gene和异种的Bio-Oss骨修复材料应用于引导组织再生术(GTR)联合植骨术在牙周骨下袋缺损的临床疗效。方法选取牙周基础治疗后仍有骨下袋缺损的牙周炎患者34例进行研究,行GTR联合植骨术的牙周再生手术,分为两组:Bio... 目的对比同种异体的Bio-Gene和异种的Bio-Oss骨修复材料应用于引导组织再生术(GTR)联合植骨术在牙周骨下袋缺损的临床疗效。方法选取牙周基础治疗后仍有骨下袋缺损的牙周炎患者34例进行研究,行GTR联合植骨术的牙周再生手术,分为两组:Bio-Gene组(n=16)和Bio-Oss组(n=18)。比较两组牙周再生术前(T0)和术后12个月(T1)的探诊深度(PD)、临床附着水平(CAL)、牙龈退缩(GR)、探诊出血(BOP)、牙齿松动度(TM)、骨缺损深度(BD)、骨内缺损深度(IBD)、剩余牙槽骨高度(RBH)及骨缺损角度(α)。结果与T0相比,T1期两组的PD、CAL、BOP、TM、BD、IBD及RBH均有显著改善(P<0.05);T1期两组相比,Bio-Gene组的BD和RBH差异显著优于Bio-Oss组(P<0.05)。结论Bio-Gene和Bio-Oss骨移植材料在短时间内均能有效改善牙周骨内缺损。值得注意的是,在降低影像学骨缺损深度方面,Bio-Gene相较于Bio-Oss表现更为优越,为牙周骨内缺损的治疗及临床应用提供新的证据。 展开更多
关键词 同种异体骨 异种骨 骨下袋 骨内缺损 植骨术 引导组织再生术
下载PDF
计算机辅助设计和计算机辅助制造预成个性化同种异体骨块在种植骨增量手术中的应用进展 被引量:1
8
作者 钟雨欣 于海洋 《国际口腔医学杂志》 CAS CSCD 北大核心 2024年第3期319-325,共7页
计算机辅助设计和计算机辅助制造(CAD/CAM)成形技术可以预成与受区更匹配的目标骨块,目前常应用于复杂的牙槽嵴增量术,通过数字化设计生产个性化的同种异体骨块,避免了传统椅旁骨块成形的步骤,大大增加了临床操作效率,提高了移植物适应... 计算机辅助设计和计算机辅助制造(CAD/CAM)成形技术可以预成与受区更匹配的目标骨块,目前常应用于复杂的牙槽嵴增量术,通过数字化设计生产个性化的同种异体骨块,避免了传统椅旁骨块成形的步骤,大大增加了临床操作效率,提高了移植物适应的精度,利于移植物的血管化和骨整合,在未来骨增量的临床应用中前景可期。因此,本文就CAD/CAM预成个性化同种异体骨块(CABB)在当前种植骨增量手术的应用现状进行综述,并进一步探讨其存在的问题和挑战。 展开更多
关键词 计算机辅助设计和计算机辅助制造 牙槽嵴增量术 同种异体骨块
下载PDF
海奥口腔生物膜单独或联合同种异骨体对颌骨囊肿术后骨缺损修复效果比较
9
作者 魏子程 周晨 +2 位作者 季炼 侯德强 董煜 《上海口腔医学》 CAS 2024年第3期285-289,共5页
目的:比较海奥口腔生物膜单独或联合同种异体骨对颌骨囊肿术后骨缺损的修复效果。方法:选择2020年11月—2022年7月入住江南大学附属医院的颌骨囊肿术后骨缺损患者105例进行前瞻性研究。按随机数字表法将患者分为海奥膜组、异体骨组和联... 目的:比较海奥口腔生物膜单独或联合同种异体骨对颌骨囊肿术后骨缺损的修复效果。方法:选择2020年11月—2022年7月入住江南大学附属医院的颌骨囊肿术后骨缺损患者105例进行前瞻性研究。按随机数字表法将患者分为海奥膜组、异体骨组和联合组。其中,海奥膜组(35例)使用海奥口腔生物膜,异体骨组(35例)使用同种异体骨,联合组(35例)联合使用海奥口腔生物膜和同种异体骨。观察并比较3组患者的临床基本资料、切口处愈合疗效、骨缺损处的骨密度、骨吸收量、附着丧失情况。采用SPSS 22.0软件包对数据进行统计学分析。结果:3组患者一般临床资料无显著差异(P>0.05)。联合组术后牙龈软组织形态恢复效果显著优于海奥膜组和异体骨组(P<0.05)。术前,3组患者骨缺损处骨密度无显著差异(P>0.05);术后6个月和12个月,3组骨密度显著改善(P<0.05),且联合组骨密度显著高于海奥膜组和异体骨组(P<0.05)。术前,3组患者垂直骨吸收量和舌侧骨吸收量无显著差异(P>0.05)。术后6个月和12个月,3组垂直骨吸收量和舌侧骨吸收量显著降低(P<0.05);联合组显著小于海奥膜组和异体骨组(P<0.05)。术前,3组患者附着丧失无显著差异(P>0.05)。术后6个月和12个月,3组附着丧失减小(P<0.05);联合组显著小于海奥膜组和异体骨组(P<0.05)。结论:海奥口腔生物膜联合同种异体骨治疗颌骨囊肿术后骨缺损疗效良好,有利于牙龈软组织恢复,改善骨密度,减少骨吸收量和附着丧失。 展开更多
关键词 海奥口腔生物膜 同种异体骨 颌骨囊肿
下载PDF
小剂量骨髓联合外周血造血干细胞移植治疗重型再生障碍性贫血18例临床研究
10
作者 彭文 唐娜娜 +6 位作者 王倩 肖青 唐晓琼 张红宾 王利 刘林 罗小华 《内科急危重症杂志》 2024年第3期229-234,269,共7页
目的:探讨小剂量骨髓联合外周血造血干细胞(PBSC)移植治疗重型再生障碍性贫血(SAA)的疗效及安全性。方法:纳入以小剂量骨髓(中位体积200 mL)联合PBSC移植治疗的18例SAA患者的临床资料,回顾分析其造血重建情况、移植物抗宿主病(GVHD)发... 目的:探讨小剂量骨髓联合外周血造血干细胞(PBSC)移植治疗重型再生障碍性贫血(SAA)的疗效及安全性。方法:纳入以小剂量骨髓(中位体积200 mL)联合PBSC移植治疗的18例SAA患者的临床资料,回顾分析其造血重建情况、移植物抗宿主病(GVHD)发生率、感染发生率及生存率等指标。结果:18例患者的中位年龄27(13~52)岁,男11例,女7例;SAA-Ⅰ型15例,SAA-Ⅱ型3例;单倍体相合供者15例,同胞全相合供者3例;预处理:氟达拉滨+环磷酰胺+抗人胸腺球蛋白方案2例,氟达拉滨+环磷酰胺+移植后环磷酰胺方案8例,氟达拉滨+环磷酰胺+抗人胸腺球蛋白+移植后环磷酰胺方案8例;采用环孢素或他克莫司+短疗程甲氨蝶呤联合吗替麦考酚酯预防GVHD。所有患者均获得造血重建,仅1例患者出现继发性移植物功能不良;10例(55.6%)出现总计19例次移植后感染,其中10例次为巨细胞病毒(CMV)或EB病毒(EBV)血症,6例次细菌感染;急性GVHD发生率为16.7%,其中Ⅰ度1例,Ⅱ度2例;慢性GVHD发生率为16.7%,均为轻度;中位随访26(2~64)个月,移植后2年总生存率为72.2%(95%CI:51.4~93.0)。5例患者死亡,4例死于肺部感染,1例死于颅内感染。结论:采用小剂量骨髓联合PBSC是SAA患者进行造血干细胞移植的有效且可行的移植物选择策略。 展开更多
关键词 小剂量骨髓 外周造血干细胞 异基因造血干细胞移植 重型再生障碍性贫血
下载PDF
磷酸钙复合重组人骨形态发生蛋白2修复和重建胫骨感染性骨缺损
11
作者 贾叙锋 龙苗 +6 位作者 黄光平 钟庆 张兆尧 齐宇新 田鹏 李萍 陈宇驰 《中国组织工程研究》 CAS 北大核心 2024年第17期2625-2630,共6页
背景:尽管Masquelet技术在临床的应用取得了广泛成功,但目前优化该技术各个环节的研究仍在不断开展,其中加快植骨后骨愈合速度、缩短骨愈合时间是医生关注的焦点。目的:观察磷酸钙复合重组人骨形态发生蛋白2材料修复胫骨感染性骨缺损的... 背景:尽管Masquelet技术在临床的应用取得了广泛成功,但目前优化该技术各个环节的研究仍在不断开展,其中加快植骨后骨愈合速度、缩短骨愈合时间是医生关注的焦点。目的:观察磷酸钙复合重组人骨形态发生蛋白2材料修复胫骨感染性骨缺损的效果。方法:选择2017年6月至2022年6月简阳市人民医院收治的感染性胫骨缺损患者31例,均接受Masquelet技术分期治疗,二期手术根据植骨材料的不同分为对照组(n=15)与研究组(n=16),对照组植入异体骨/自体骨颗粒,研究组植入磷酸钙复合重组人骨形态发生蛋白2/自体骨颗粒。二期术后6个月,检测患者外周血白细胞数、C-反应蛋白、血沉等炎性指标,记录影像学骨愈合时间、骨愈合X射线评分、骨缺损愈合分级和邻近关节功能,观察是否存在钉道感染、植入吸收、取骨区疼痛、感染等情况。结果与结论:①两组患者二期术后6个月外周血白细胞计数、血沉、C-反应蛋白水平均低于一期术前(P<0.05),两组间各指标比较差异无显著性意义(P>0.05);②研究组骨愈合时间短于对照组(P<0.05);③研究组患者二期术后6个月的骨愈合X射线评分高于对照组(P<0.05),骨缺损愈合优良率与邻近关节功能优良率均高于对照组(P<0.05);两组间感染复发率与并发症发生率比较差异均无显著性意义(P>0.05);④结果表明,Masquelet技术二期术中应用磷酸钙复合重组人骨形态发生蛋白2治疗胫骨感染性骨缺损的愈合效果良好、安全性高。 展开更多
关键词 胫骨感染性骨缺损 诱导膜技术 自体骨 异体骨 磷酸钙 骨形态发生蛋白2 人工骨
下载PDF
人工骨浆联合同种异体骨治疗对四肢骨缺损患者愈合情况及生活质量的影响
12
作者 陈吉冰 邱苗 胡芳 《中国医学创新》 CAS 2024年第25期34-38,共5页
目的:探究人工骨浆联合同种异体骨治疗对四肢骨缺损患者愈合情况及生活质量的影响。方法:选取102例于2021年5月—2023年12月在赣南医科大学第二附属医院进行治疗的四肢骨缺损患者作为研究对象,进行回顾性分析。根据治疗方式的不同将患... 目的:探究人工骨浆联合同种异体骨治疗对四肢骨缺损患者愈合情况及生活质量的影响。方法:选取102例于2021年5月—2023年12月在赣南医科大学第二附属医院进行治疗的四肢骨缺损患者作为研究对象,进行回顾性分析。根据治疗方式的不同将患者分为异体骨组(n=46,给予单纯同种异体骨治疗)、联合组(n=56,给予人工骨浆联合同种异体骨治疗)。比较两组愈合情况、愈合效果及生活质量。结果:联合组愈合时间早于异体骨组,差异有统计学意义(P<0.05)。两组并发症发生率比较,差异无统计学意义(P>0.05)。联合组和异体骨组术前VAS评分比较,差异无统计学意义(P>0.05);联合组和异体骨组术后24 h VAS评分较术前均降低,且联合组术后24 h VAS评分低于异体骨组,差异均有统计学意义(P<0.05)。联合组术后3个月X射线评分高于异体骨组,差异有统计学意义(P<0.05)。联合组和异体骨组术前健康调查量表36(SF-36)评分比较,差异均无统计学意义(P>0.05);联合组和异体骨组术后3个月SF-36评分均较术前升高,且联合组术后3个月SF-36评分均高于异体骨组,差异均有统计学意义(P<0.05)。结论:与单纯同种异体骨治疗相比,人工骨浆联合同种异体骨治疗四肢骨缺损,患者愈合时间短、术后疼痛感轻,有助于生活质量提高,且安全性高。 展开更多
关键词 人工骨浆 同种异体骨 四肢骨缺损 愈合效果 生活质量
下载PDF
自体骨+异体骨填充修复膝周骨巨细胞瘤治疗后骨缺损
13
作者 夏平光 蒋翔 +1 位作者 张宝成 赵东东 《临床骨科杂志》 2024年第1期111-111,共1页
2015年1月~2020年12月,我科采用自体骨+异体骨填充修复27例膝周骨巨细胞瘤微波原位消融术后骨缺损患者,疗效满意,报道如下。1材料与方法1.1病例资料本组27例,男11例,女16例,年龄19~52岁。病变部位:股骨远端12例,胫骨近端15例。按照骨巨... 2015年1月~2020年12月,我科采用自体骨+异体骨填充修复27例膝周骨巨细胞瘤微波原位消融术后骨缺损患者,疗效满意,报道如下。1材料与方法1.1病例资料本组27例,男11例,女16例,年龄19~52岁。病变部位:股骨远端12例,胫骨近端15例。按照骨巨细胞瘤的Campanacci系统分级:Ⅰ级9例,Ⅱ级11例,Ⅲ级7例。1.2手术方法全身麻醉或腰硬联合麻醉。患者仰卧位,患侧垫高。 展开更多
关键词 骨巨细胞瘤 自体骨 异体骨 骨缺损
下载PDF
人工骨浆联合同种异体骨治疗四肢骨折骨缺损的应用
14
作者 陈吉冰 顾卢妹 肖曜升 《中国当代医药》 CAS 2024年第14期21-24,共4页
目的探究人工骨浆联合同种异体骨治疗四肢骨折骨缺损的应用价值。方法选取2021年8月至2022年8月于赣南医学院第二附属医院接受手术的160例四肢骨折骨缺损患者作为研究对象,采用随机数字表法将其分为对照组、人工骨浆组、异体骨组和联合... 目的探究人工骨浆联合同种异体骨治疗四肢骨折骨缺损的应用价值。方法选取2021年8月至2022年8月于赣南医学院第二附属医院接受手术的160例四肢骨折骨缺损患者作为研究对象,采用随机数字表法将其分为对照组、人工骨浆组、异体骨组和联合治疗组,每组各40例。对照组患者采取自体松质骨填充于骨缺损部位;异体骨组患者取骨组织库中提供的同种异体骨在骨缺损处填实;人工骨浆组使用人工骨浆,手动塑形后挤压到骨空隙处进行填充,联合治疗组联合骨浆和同种异体骨在骨缺损位置进行填充。比较四组患者的围手术期指标、影像学情况、功能评分及并发症发生情况。结果联合治疗组的术中出血量、术后引流量、手术费用均少于其他三组,且手术时间、住院时间均短于其他三组,差异有统计学意义(P<0.05);联合治疗组的生活质量健康调查简表(SF-36)评分、诺丁汉健康量表(NHP)评分、视觉模拟评分法(VAS)满意度评分均高于其他三组,且VAS疼痛评分均低于其他三组,差异有统计学意义(P<0.05);影像学情况显示,联合治疗组患者6个月后X线示植骨处均有骨痂生长,且1年骨性愈合率均高于其他三组,差异有统计学意义(P<0.008);联合治疗组的并发症总发生率低于其他三组,差异有统计学意义(P<0.008)。结论针对四肢骨折骨缺损患者,采取人工骨浆联合同种异体骨治疗有助于改善患者围手术期指标、促进骨愈合速度,同时降低并发症发生率并提高生活质量,且总体治疗的安全性更高。 展开更多
关键词 人工骨浆 同种异体骨 四肢骨折骨缺损 围手术期指标 影像学情况 功能评分 安全性
下载PDF
骨形态发生蛋白-2(BMP-2)与同种异体骨在治疗胫骨平台骨折的疗效比较
15
作者 赵际童 唐伟华 +3 位作者 顾建伟 曹晓东 陈俊峰 骆园 《生物骨科材料与临床研究》 CAS 2024年第1期46-50,共5页
目的比较骨形态发生蛋白2(bone morphogenetic protein-2,BMP-2)与同种异体骨在治疗单纯胫骨平台外侧塌陷骨折的临床治疗效果。方法选择2019年1月至2022年1月在苏州大学附属太仓医院接受手术治疗的80例单纯性胫骨外侧平台骨折的患者。... 目的比较骨形态发生蛋白2(bone morphogenetic protein-2,BMP-2)与同种异体骨在治疗单纯胫骨平台外侧塌陷骨折的临床治疗效果。方法选择2019年1月至2022年1月在苏州大学附属太仓医院接受手术治疗的80例单纯性胫骨外侧平台骨折的患者。将其按照骨移植方法分为BMP组(40例)与同种异体骨组(40例),BMP组采用BMP-2移植修复,同种异体骨组采用同种异体骨移植修复。比较两组患者的手术时间、术中出血量、住院时间、早期完全负重时间、术后并发症。采用X线检查评估内固定和骨折愈合的情况,用术后12个月的内翻角、后倾角、Rasmussen放射学评分评估骨折复位后的效果,HSS膝关节功能评分评估膝关节功能,Fugl-Meyer运动功能评分评定运动功能。结果两组患者均随访12~16个月,平均(13.73±1.67)个月。BMP组的住院时间[(9.80±1.24)d]、骨折愈合时间[(13.30±2.05)周]、早期完全负重时间[(13.43±1.78)周]以及并发症(5%)明显小于同种异体骨组[(11.47±4.81)d、(14.03±1.95)周、(14.08±1.58)周、22.5%],两组比较差异有统计学意义(P<0.05)。两组的手术时间、术中出血量、术后12个月的内翻角、后倾角、Rasmussen影像学塌陷评分及Rasmussen影像学总评分比较,差异无统计学意义(P>0.05)。两组术后12个月膝关节HSS评分都达到了优良;FMA评分也提示下肢功能恢复情况比较差异无统计学意义(P>0.05)。结论与同种异体骨相比,采用BMP-2治疗胫骨平台骨折可以减少住院时间,加速骨折愈合,减少早期完全负重的时间及术后并发症,有利于早期康复。 展开更多
关键词 骨形态发生蛋白 同种异体骨 胫骨平台骨折 骨折内固定
下载PDF
同种异体腱重建前交叉韧带术后胫骨侧继发巨大骨囊肿1例
16
作者 季卫平 程捷 +1 位作者 雷恒傲 李浩 《临床骨科杂志》 2024年第2期283-283,共1页
患者,男,66岁,因右膝前交叉韧带重建术后4年、疼痛1年于2022年11月16日来我院就诊。4年前患者因右膝前交叉韧带断裂、外侧副韧带损伤在我院行关节镜下同种异体腱移植重建,术后恢复膝关节稳定并正常行走。1年前出现膝前下疼痛,逐渐加重... 患者,男,66岁,因右膝前交叉韧带重建术后4年、疼痛1年于2022年11月16日来我院就诊。4年前患者因右膝前交叉韧带断裂、外侧副韧带损伤在我院行关节镜下同种异体腱移植重建,术后恢复膝关节稳定并正常行走。1年前出现膝前下疼痛,逐渐加重。无肿瘤家族史及外伤史。查体:生命体征平稳;右膝无红肿,皮温正常,轻度外翻,主动伸直0°、屈曲110°,前抽屉试验(+),膝前下压痛(+),行走不稳感加重;右足底和足趾血供、感觉、活动良好。 展开更多
关键词 同种异体腱 交叉韧带重建 胫骨骨囊肿
下载PDF
自体带骨膜髂骨移植与同种异体骨骨粉联合PRP治疗距骨骨软骨损伤的治疗效果比较研究
17
作者 吴苏琪 吴寒松 +2 位作者 余冬梅 陈琼 池蓉蓉 《中国现代医生》 2024年第5期40-43,共4页
目的分析并对比自体带骨膜髂骨移植与同种异体骨骨粉联合富血小板凝胶(platelet rich gel,PRP)治疗HeppleⅤ型距骨骨软骨损伤(osteochondral injury,OLT)。方法选取浙江中医药大学附属金华中医院2018年10月至2022年10月收入的HeppleⅤ型... 目的分析并对比自体带骨膜髂骨移植与同种异体骨骨粉联合富血小板凝胶(platelet rich gel,PRP)治疗HeppleⅤ型距骨骨软骨损伤(osteochondral injury,OLT)。方法选取浙江中医药大学附属金华中医院2018年10月至2022年10月收入的HeppleⅤ型OLT患者62例为研究对象,根据其治疗方式将其分为移植组(接受自体带骨膜髂骨移植治疗,31例)、联合组(接受同种异体骨骨粉联合PRP治疗,31例)。对患者进行术后12个月门诊随访研究,评估并比较两组患者术后12个月治疗效果、踝关节活动度(range of motion,ROM)、美国骨科足踝外科学会(American Society of Orthopedic Foot andAnkle Surgeons,AOFAS)踝-后足评分、疼痛评分、满意度、并发症发生率差异。结果移植组治疗总有效率(96.77%)与联合组(93.55%)相比,差异无统计学意义(P>0.05)。术后12个月两组ROM、AOFAS评分均改善(P<0.05),组间差异无统计学意义(P>0.05)。两组患者术后1个月、3个月、6个月、12个月,两组疼痛评分均较术前有所降低(P<0.05)。移植组患者主观总满意度(77.42%),低于联合组(96.77%,P<0.05)。移植组并发症总发生率(19.35%)与联合组(3.23%)相比,明显更高(P<0.05)。结论同种异体骨骨粉联合PRP可避免额外手术切口,患者主观满意度更高,术后并发症发生率低。 展开更多
关键词 带骨膜髂骨 异体骨骨粉 富血小板凝胶 距骨骨软骨损伤
下载PDF
The Osteogenic Capacity of Human Amniotic Membrane Mesenchymal Stem Cell (hAMSC) and Potential for Application in Maxillofacial Bone Reconstruction <i>in Vitro</i>Study 被引量:2
18
作者 David B. Kamadjaja Purwati   +2 位作者 Fedik A. Rantam Ferdiansyah   Coen Pramono 《Journal of Biomedical Science and Engineering》 2014年第8期497-503,共7页
Amniotic membrane of human placenta is a source of abundant mesenchymal stem cell (hAMSC) which makes it a potential source of allogeneic multipotent cell for bone healing. However, much has to be explored about its i... Amniotic membrane of human placenta is a source of abundant mesenchymal stem cell (hAMSC) which makes it a potential source of allogeneic multipotent cell for bone healing. However, much has to be explored about its isolation procedure and the osteogenic differentiation potential. The aims of this study are to establish the procurement procedure of human amniotic membrane, the isolation and culture of hAMSC, the MSC phenotypic characterization, and the in vitro osteogenic differentiation of hAMSC. Results of the study are as follows. The quality of human amniotic membrane would be best if procured from Caesarean operation under highly aseptic condition to avoid fungal and bacterial contamination on the culture. Isolation procedure using modified Soncini protocol yielded large amount of MSC with high proliferative capacity in culture medium. Characterization of hAMSC showed that the majority of the target cells exhibited specific MSC markers (CD105 and CD90) with a small number of these cells expressing CD45, the marker of hematopoeitic cells. The in vitro osteogenic differentiation of hAMSC followed by Alizarin Red staining showed that osteoblastic differentiation was detected in a significantly high number of cells. This study concludes that hAMSCs isolated from human amniotic membrane have the capacity for in vitro osteogenesis which makes them be one of the potential allogeneic stem cells for application in maxillofacial bone reconstruction. 展开更多
关键词 Human Amniotic Membrane Mesenchymal STEM Cells Modified Soncini Protocol MSC Phenotypic Characterization OSTEOGENIC Differentiation allogenEIC STEM Cell MAXILLOFACIAL bone Reconstruction
下载PDF
Attenuation of GVHD for Allo-Bone Marrow Transplantation Recipient by FasL-Fas Pathway in an H-2 Haplotype Disparate Mouse Combination
19
作者 刘凌波 邹萍 +4 位作者 胡中波 仲照东 肖娟 郭荣 徐之良 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2004年第4期329-333,共5页
In order to explore a new special and effective way to prevent graft versus host disease (GVHD) after allogenic bone marrow transplantation (allo-BMT), the stem cell antigen-1 (Sca-1) + early hematopoietic cells (EHC... In order to explore a new special and effective way to prevent graft versus host disease (GVHD) after allogenic bone marrow transplantation (allo-BMT), the stem cell antigen-1 (Sca-1) + early hematopoietic cells (EHC) from BALB/c mouse (H-2 d) were introduced with exogenous mouse Fas ligand (mFasL) cDNA gene by the retrovirus-mediated gene transfer and expanded for one week, and then they were co-cultured with the spleen mononuclear cells (SMNC) from BAC mouse (H-2 d×b) as one way mixed lymphocyte reaction (OWMLR). The cytotoxicity of treated BAC mouse SMNC against Na 2 51CrO 4 labeling SMNC from BALB/c mouse was observed. The bone marrow mononuclear cells (BMMNC) from BAC mouse treated by the above methods were transplanted into lethally-irradiated congenic BALB/c mice to observe the occurrence of GVHD. The results showed that the SMNC from BAC mouse after OWMLR with exogenous mFasL cDNA gene-transduced hematopoietic cells (HC) from BALB/c mouse in a ratio of 1 to 5 exhibited an obvious inhibition of the cytotoxicity against the BALB/c mouse spleen cells at different effector/target ratios as compared to the control group (P<0.01). The gradeⅠ GVHD or no GVHD and the 80 % survival rate at day 60 post-BMT were observed in the BALB/c mouse receiving BAC mouse BMMNC treated with similar way, while the grade Ⅱ-Ⅲ GVHD and the 20 % survival rate were noted in the control group (P<0.01). It is suggested that the attenuation of GVHD in allo-BMT recipient could be successfully achieved through FasL-Fas pathway in an H-2 haplotype disparate mouse combination. 展开更多
关键词 Fas ligand Fas allogenic bone marrow transplantation graft versus host disease
下载PDF
The Use of Cortical Bone Wedges from the Mandibular Ramus “Wedge Technique”: For 3-Dimensional Bone Augmentation of the Atrophic Ridges. Technique Presentation and Report of Case Series
20
作者 Fares Kablan 《Open Journal of Stomatology》 2018年第6期217-239,共23页
Purpose: Autogenous bone was still considered as the gold standard in bone augmentations prior to implants insertion at the atrophic ridges. However if large bone grafts are needed to augment multiple edentulous atrop... Purpose: Autogenous bone was still considered as the gold standard in bone augmentations prior to implants insertion at the atrophic ridges. However if large bone grafts are needed to augment multiple edentulous atrophic segments, extraoral donor sites may be mandatory. The aim of this report is to introduce the Fares Wedge Technique, as a new bone augmentation method that can augment multiple edentulous ridges with intraoral cortical bone grafts. Methods: This report includes patients with moderate to severe ridge atrophy in different regions of the both jaws who were treated over 6-years period (2009-215) with wedge Technique (WT). Patients received panorex immediately after the surgery, and they were examined clinically and radiographically (periapical) every 2 weeks. At 4 months, computed tomography was performed to evaluate the bone gain. Reentry was performed after 4 to 5 months to evaluate the new bone volume and quality and to insert implants. At this stage specimens for histologic examination were also obtained. Results: 39 augmentation sites in 22 patients (15 women, 7 men: mean age 47 years) were followed 12 to 52 months. The healing process was uneventful, with minimal morbidity. The success rate was 95%, and the bone gain average was 3 - 6 mm vertically and 3 - 9 mm horizontally. In two patients the graft was partially exposed and treated with shaving and rounding the exposed wedges, but the augmentations were saved. In one case the majority of the bone graft was lost. At 38 sites the patients had successfully received 114 implants. Conclusions: wedge technique can augment multiple segments of atrophic ridges with small amount of autogenic graft. The bone volume that achieved was satisfying, especially that the majority of the augmented areas were at posterior mandibular defects. 展开更多
关键词 bone Augmentation Autogenic bone GRAFTS allogenic bone Substitute Donor Site Space Maintenance
下载PDF
上一页 1 2 26 下一页 到第
使用帮助 返回顶部